These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 17229070)
1. Beneficial effects of CCR1 blockade on the progression of chronic renal allograft damage. Bedke J; Kiss E; Schaefer L; Behnes CL; Bonrouhi M; Gretz N; Horuk R; Diedrichs-Moehring M; Wildner G; Nelson PJ; Gröne HJ Am J Transplant; 2007 Mar; 7(3):527-37. PubMed ID: 17229070 [TBL] [Abstract][Full Text] [Related]
2. Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice. Anders HJ; Belemezova E; Eis V; Segerer S; Vielhauer V; Perez de Lema G; Kretzler M; Cohen CD; Frink M; Horuk R; Hudkins KL; Alpers CE; Mampaso F; Schlöndorff D J Am Soc Nephrol; 2004 Jun; 15(6):1504-13. PubMed ID: 15153561 [TBL] [Abstract][Full Text] [Related]
3. CCR1-specific non-peptide antagonist: efficacy in a rabbit allograft rejection model. Horuk R; Shurey S; Ng HP; May K; Bauman JG; Islam I; Ghannam A; Buckman B; Wei GP; Xu W; Liang M; Rosser M; Dunning L; Hesselgesser J; Snider RM; Morrissey MM; Perez HD; Green C Immunol Lett; 2001 Apr; 76(3):193-201. PubMed ID: 11306147 [TBL] [Abstract][Full Text] [Related]
4. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome. Vielhauer V; Berning E; Eis V; Kretzler M; Segerer S; Strutz F; Horuk R; Gröne HJ; Schlöndorff D; Anders HJ Kidney Int; 2004 Dec; 66(6):2264-78. PubMed ID: 15569315 [TBL] [Abstract][Full Text] [Related]
5. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. Gao W; Topham PS; King JA; Smiley ST; Csizmadia V; Lu B; Gerard CJ; Hancock WW J Clin Invest; 2000 Jan; 105(1):35-44. PubMed ID: 10619859 [TBL] [Abstract][Full Text] [Related]
6. Protective effects of atorvastatin on chronic allograft nephropathy in rats. Zhang W; Liu M; Wu Y; Zhu P; Yin C; Zhang W; Gu M J Surg Res; 2007 Dec; 143(2):428-36. PubMed ID: 17628598 [TBL] [Abstract][Full Text] [Related]
7. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection. Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698 [TBL] [Abstract][Full Text] [Related]
8. Differential expression of beta-chemokines MCP-1 and RANTES and their receptors CCR1, CCR2, CCR5 in acute rejection and chronic allograft nephropathy of human renal allografts. Rüster M; Sperschneider H; Fünfstück R; Stein G; Gröne HJ Clin Nephrol; 2004 Jan; 61(1):30-9. PubMed ID: 14964455 [TBL] [Abstract][Full Text] [Related]
9. A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection. Horuk R; Clayberger C; Krensky AM; Wang Z; Grone HJ; Weber C; Weber KS; Nelson PJ; May K; Rosser M; Dunning L; Liang M; Buckman B; Ghannam A; Ng HP; Islam I; Bauman JG; Wei GP; Monahan S; Xu W; Snider RM; Morrissey MM; Hesselgesser J; Perez HD J Biol Chem; 2001 Feb; 276(6):4199-204. PubMed ID: 11054419 [TBL] [Abstract][Full Text] [Related]
11. Expression of the chemokine receptor CCR1 in human renal allografts. Mayer V; Hudkins KL; Heller F; Schmid H; Kretzler M; Brandt U; Anders HJ; Regele H; Nelson PJ; Alpers CE; Schlöndorff D; Segerer S Nephrol Dial Transplant; 2007 Jun; 22(6):1720-9. PubMed ID: 17298994 [TBL] [Abstract][Full Text] [Related]
12. A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. Anders HJ; Vielhauer V; Frink M; Linde Y; Cohen CD; Blattner SM; Kretzler M; Strutz F; Mack M; Gröne HJ; Onuffer J; Horuk R; Nelson PJ; Schlöndorff D J Clin Invest; 2002 Jan; 109(2):251-9. PubMed ID: 11805137 [TBL] [Abstract][Full Text] [Related]
13. Early application of Met-RANTES ameliorates chronic allograft nephropathy. Song E; Zou H; Yao Y; Proudfoot A; Antus B; Liu S; Jens L; Heemann U Kidney Int; 2002 Feb; 61(2):676-85. PubMed ID: 11849411 [TBL] [Abstract][Full Text] [Related]
14. Chemokine receptor CCR1: a new target for progressive kidney disease. Ninichuk V; Anders HJ Am J Nephrol; 2005; 25(4):365-72. PubMed ID: 16088077 [TBL] [Abstract][Full Text] [Related]
15. Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity. Shihab FS; Yi H; Bennett WM; Andoh TF Kidney Int; 2000 Sep; 58(3):1174-85. PubMed ID: 10972680 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic targeting of CCR1 attenuates established chronic fungal asthma in mice. Carpenter KJ; Ewing JL; Schuh JM; Ness TL; Kunkel SL; Aparici M; Miralpeix M; Hogaboam CM Br J Pharmacol; 2005 Aug; 145(8):1160-72. PubMed ID: 15951834 [TBL] [Abstract][Full Text] [Related]
17. Macrophages contribute to cellular but not humoral mechanisms of acute rejection in rat renal allografts. Ma FY; Woodman N; Mulley WR; Kanellis J; Nikolic-Paterson DJ Transplantation; 2013 Dec; 96(11):949-57. PubMed ID: 24056626 [TBL] [Abstract][Full Text] [Related]
18. Macrophage colony-stimulating factor expression and macrophage accumulation in renal allograft rejection. Le Meur Y; Jose MD; Mu W; Atkins RC; Chadban SJ Transplantation; 2002 Apr; 73(8):1318-24. PubMed ID: 11981428 [TBL] [Abstract][Full Text] [Related]